Get started

Vaccinestocks

JOHNSON & JOHNSON (JNJ)In my work, I always try to combine fundamental analysis and technical analysis. They are both important, especially on a topic as important as the covid vaccine. Johnson & Johnson is about to be marketed, after the approval of the EMA on 11 March. Exactly after the announcement, I bought the stock. The JnJ vaccine has a much lower distribution cost than Pfizer since it can be stored at refrigerator temperatures, like AstraZeneca. The difference is in the prestige and history that the company has. Moreover, the share according to the average of analysts, still has ample room for growth, with an average target of $ 185 and a second "high" at $ 200. Technically speaking, the price bounced off the bullish support trendline on Thursday, March 4th, and then broke the resistance trendline on the 12th, exactly the day after the announcement of the EMA's approval. The trend is clearly bullish, but, even keeping in mind the analysts' opinion, I believe the first target in area 170 is more likely. If everything goes well with the vaccine, the analyst targets could be greatly raised. It is a different trade, to be constantly monitored with a trailing stop, in case there will be any hitches or cases of a block, as happened for AstraZeneca. Such an open market scenario would cause a crash, so you have to be ready to get out quickly. Lazy Bull 1st target: 170 2nd target: 180 3rd target: 200 DISCLAIMER: I am not a financial advisor nor a CPA. These posts, videos, and any other contents are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
NYSE:JNJLong
by LazyBull5
2
PFIZER: Covid's Decision !On PFIZER , H1 timeframe price is around a critical decision zone, so what can we expect here: 1. Global Recover: If the fundamentals are positive, then the chart will be bullish and we will go into the 1st scenario where price continues to trade inside the channel until it reaches the resistance zone were we can look for sell setups. 2. Failure: Unlike the first one, the price hasn't broken aggressively yet the resistance where it's standing, so it can move downward into the zone, trade there for a couple of days since it doesn't have great volatility and goes down bearishly to reach the support. This scenario can be imagined if the global reaction to the vaccine remain negative or any unprecedented medical issue happens. Until then, Trade Safe and Best of Luck ! MacroForex
NYSE:PFE
by Therealsmaira
Covid vaccine play 🚀🚀🚀VBIV CEO Baxter said on a feb 5 2021 podcast that human trials were to begin in the next couple of weeks for their single dose monovalent covid vaccine vbi-2902, which received $56 Million from Canada to produce a vaccine. Today moderna announced forecasted sales of ~$18 Billion just from covid vaccine sales. Once VBi announces initiation of human trials for the ph1/2 study planned in Canada, I’m expecting a sizeable move to the upside. Cup and handle - handle retraced to FIBO 618 retrace net which is a nice area to see bounce. I see potential to test The previous high of $6.98 as perceptive advisors did not sell any shares after loading bigly sub-$1 prior to that run which was over 1000% incl trade for them. This shows they expect SP to move significantly higher or fhey would have sold a percentage to re add on dips after that massive run. With all the catalysts in 2021, GBM treatment with eVLP , SCI-b-vac and hepB therapeutic, pan-corona vaccine and this single dose vaccine, I see no reason why this can’t be double digits by year end. Please like and follow! 🚀🚀🚀🚀 Disclosure: not investment advice as I am not a financial advisor. This information is to be used for educational purposes only.
VLong
by follow_the_money
2
MRNA: a misleading cup with a handle formation?MRNA’s short-, long and mid-term trend charts are presented. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:MRNA
by Gnothisafton
4
INO: golden cross on the 12h chartINO’s long and mid-term trend charts are presented. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:INOLong
by Gnothisafton
2
INO practices trigonometryINO’s short-term trend chart is presented. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:INOLong
by Gnothisafton
2
MRNA: a bigger cup with a handle pattern is formingMRNA’s short-, long- and mid-term trend charts are presented. In both the weekly and daily charts the trend continues to be rising.____ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:MRNALong
by Gnothisafton
INO: over the 200d SMA againINO’s short-, long - and mid- trend charts are presented. The trend in both the weekly and the daily charts continues to be rising. ____ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:INOLong
by Gnothisafton
2
INO: it’s like riding a bullINO’s short-, long - and mid- trend charts are presented. The trend in both the weekly and the daily charts continues to be rising. Because of the strong volatility of the stock it is like riding a bull that constantly tries to throw you off its back (stock’s market maker is extremely competent and makes very abrupt changes in prices), we remain bought into the stock for as long as MACD's weekly buying signal lasts . Only very experienced traders can exploit the mid- and short-term buying and selling signals without staying out of the long-term trend. Good luck to all the Inovians! Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:INOLong
by Gnothisafton
2
MRNA: a very perfect cup with a handle pattern to be true?MRNA’s short-, mid- and long-term trend are presented. In both the weekly and daily charts the trend continues to be rising. We remain bullish as long as the mid-term trend is rising regardless of the short-term moves. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:MRNALong
by Gnothisafton
MRNA seems ready to continue its risingThe short-term trend chart of MODERNA is presented. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:MRNALong
by Gnothisafton
1
MRNA (TESLA of biotechnology) towards new highsAfter making a major price correction throughout December, MRNA started in 2021 a new upward movement that is ongoing and leading it to new highs. Note that 1) the correction was made with a very large volume, which means that the shares left the portfolios of the many and passed into those of the few 2) the RSI has not yet entered the overbought area and 3) it is possible (but perhaps not necessary) to retreat prices close to the previous peak to create a cup-forming handle. MRNA's upward move is supported by both the expected big sales revenue of its vaccine for Covid-19, and a promising large pipeline of new drugs and vaccines comprising 27 products under development. MRNA as well as INO is likely the TESLA of Biotechnology. Following is presented the short-term trend chart of the stock. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:MRNALong
by Gnothisafton
1
The time to wake up the stock of giant Sinopharm is nearSinopharm Group is a profitable Chinese state company with 2 covid-19 vaccines (the first is approved in China) with very strong fundamentals (except debt). Sinopharms stock seems to be near the end of a many years correction, ready to reverse its declining trend. Next follows the stocks mid-term trend chart. Disclaimer The writer of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
FWB:X2SLong
by Gnothisafton
You pick! Vaccine stocks +265%, FAANG +32%As of 2/12/2020 to date, vaccine stocks (MRNA,BNTX,NVAX,AZN,VIR,ARCT,INO,TBIO,VXRT) had a 233% outperformance against FAANG technology stocks (FB,AMZN,AAPL,NFLX,GOOG). This trend of outperformance is likely to continue in the coming period because valuations of tech stocks need to be held at reasonable levels to avoid a sharp collapse of NASDAQ one day. On the other hand, the stock prices of vaccines have to integrate in advance the forecasts of vaccine demand for several more years (unfortunately), as well as the development of new treatments in all kinds of diseases with new methods of Biotechnology (mRNA, DNA, Gene editing etc.). Below are presented the mid-term trend charts of Vaccine and FAANG stocks. Notice that the Vaccine stocks trend is upward (in both RSI and MACD) while the FAANG stocks trend is downward. Disclaimer The writer of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:META
by Gnothisafton